S.
No |
Age
(Years) |
Male |
Female |
Total |
Socio-economic status |
||||||
No
|
% |
No |
% |
No |
% |
S.
No |
Class
|
No
|
% |
||
1. |
0-5 |
71 |
06.67 |
52 |
04.88 |
123 |
11.55 |
1. |
Lower
|
871 |
81.78 |
2. |
6-20 |
237 |
22.25 |
116 |
10.89 |
353 |
33.15 |
||||
3. |
21-40 |
220 |
20.66 |
156 |
14.62 |
376 |
35.31 |
2. |
Middle
|
175 |
16.43 |
4. |
41-60 |
100 |
09.39 |
48 |
04.53 |
148 |
13.90 |
||||
5. |
61-80 |
46 |
04.32 |
16 |
01.51 |
62 |
05.82 |
3. |
Upper
|
19 |
01.78 |
6. |
≥
80 |
03 |
00.28 |
00 |
00.00 |
03 |
00.28 |
||||
Total |
677 |
63.57 |
388 |
36.43 |
1065 |
100 |
Total |
1065 |
100 |
S.
No |
Site |
Total |
Symptoms |
Sign (n=304)-IPD |
|||||
No
|
% |
Complaints |
No. |
% |
Findings |
No. |
% |
||
1. |
Lower
limb |
354 |
33.24 |
Pain
|
1055 |
99.06 |
Tachycardia
|
139 |
45.72 |
2. |
Upper
limb |
252 |
23.66 |
Swelling
|
1056 |
99.15 |
Pallor
|
85 |
27.96 |
3. |
Thorax
|
102 |
09.58 |
Fever
|
578 |
54.27 |
Fever
|
42 |
13.82 |
4. |
Breast
|
87 |
08.17 |
Discharge
|
124 |
11.64 |
Sepsis
|
15 |
04.93 |
5. |
Trunk
|
87 |
08.17 |
Loss
of function |
07 |
02.30 |
Regional
Lymphadenopathy |
11 |
03.62 |
6. |
Head
& Neck |
65 |
06.10 |
Cause of Abscesses |
Tenderness
|
304 |
100 |
||
7. |
Perineum |
68 |
06.38 |
Not
known |
847 |
79.53 |
Fluctuation |
267 |
87.80 |
8. |
Multiple |
50 |
04.69 |
Trauma
|
140 |
13.15 |
Skin
changes |
283 |
93.12 |
Total |
1065 |
100 |
Post
injection |
78 |
07.32 |
|
|
|
S.
No |
Type
of intervention |
No.
of cases |
% |
Total
|
Grand
Total |
|
1. |
Application
of local remedies |
Non-medical
intervention |
61 |
20.07 |
40.46% |
74.67% |
2. |
Hot
fomentation |
50 |
16.45 |
|||
3. |
Massage
|
12 |
03.94 |
|||
4. |
Antibiotics
and analgesics |
Medical
intervention |
58 |
19.08 |
34.21% |
|
5. |
Analgesic
only |
41 |
13.49 |
|||
6. |
Incision
and drainage |
05 |
01.64 |
|||
7. |
No
treatment |
|
77 |
25.33 |
25.33 |
25.33 |
Total |
304 |
100 |
100 |
100 |
S. No. |
Hemoglobin (Gm%) |
TLC |
RBS (mg%) |
Puss
culture |
||||||||
Range
|
No
|
% |
Range
|
No
|
% |
Range |
No |
% |
Result
|
No
|
% |
|
1. |
3-6 |
04 |
01.92 |
5500-8500 |
37 |
17.79 |
<130 |
198 |
81.48 |
Positive |
111 |
55.55 |
2. |
7-10 |
132 |
63.46 |
8500-11000 |
75 |
36.06 |
130-160 |
33 |
13.58 |
Negative |
89 |
44.45 |
3. |
>10 |
72 |
34.62 |
>11000 |
96 |
46.15 |
>160 |
12 |
04.94 |
- |
- |
- |
Total
|
|
208 |
100 |
|
208 |
100 |
|
243 |
|
|
200 |
100 |
S.
No |
Organism Grown |
No
of cases |
% |
Amikacin
|
Gentamicin
|
Ciprofloxacin |
Ceftriaxone
|
Cefuroxime |
Cefotaxime
|
Clarithromicin |
1. |
Staphylococcus
aureus |
80 |
72 |
93.7 |
81.0 |
50.0 |
84.3 |
87.5 |
55.0 |
82.5 |
2. |
Klebsiella
aeruginosa |
12 |
11 |
91.0 |
83.0 |
25.0 |
83.0 |
50.0 |
50.0 |
75.0 |
3. |
E.
coli |
10 |
09 |
70.0 |
90.0 |
80.0 |
70.0 |
70.0 |
70.0 |
80.0 |
4. |
Pseudomonas |
09 |
08 |
78.0 |
66.0 |
20.0 |
67.0 |
55.0 |
55.0 |
66.0 |